Cancer Research UK logo.
SearchDonate
  • Search

A trial looking at capecitabine and aflibercept for bowel cancer that has spread elsewhere in the body (CAPITAL)

Overview

Cancer types:

Bowel (colorectal) cancer, Colon cancer, Rectal cancer

Status:

Closed

Phase:

Phase 2

Details

This trial is looking at 2 drugs called capecitabine and aflibercept for people who have bowel cancer that has spread elsewhere in the body.

Recruitment start: 31 March 2014

Recruitment end: 31 December 2018

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Paul Ross

Supported by

Experimental Cancer Medicine Centre (ECMC)

Guy's and St Thomas' NHS Foundation Trust

Sanofi Aventis

Last reviewed: 02 Jan 2019

CRUK internal database number: 11777

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.